Evidence map›Paper›PMID 42336836›Full record

ArticleBlood cancer journal2026

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Laurène Fenwarth, Loïc Vasseur, Nicolas Duployez, Augustin Boudry, Claude Gardin, Dominique Penther, Juliette Lambert, Stéphane de Botton, Karine Celli-Lebras, Pascal Turlure and 10 more

Abstract read
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Laurène FenwarthLaboratory of Hematology, CHU Lille, Lille, France. laurene.fenwarth@chu-lille.fr.ORCID http://orcid.org/0000-0003-2808-4843
Loïc VasseurAdolescents and Young Adults Hematology Unit, Saint Louis University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.ORCID http://orcid.org/0000-0001-9065-0477
Nicolas DuployezLaboratory of Hematology, CHU Lille, Lille, France.ORCID http://orcid.org/0000-0002-3927-1022
Augustin BoudryLaboratory of Hematology, CHU Lille, Lille, France.ORCID http://orcid.org/0000-0002-9154-1085
Claude GardinDepartment of Hematology, Université Paris Nord, Hôpital Avicenne, AP-HP, Bobigny, France.
Dominique PentherLaboratory of Genetic Oncology, Centre Henri Becquerel, Rouen, France.
Juliette LambertDepartment of Hematology, Hôpital André Mignot, Université de Versailles-Saint Quentin, Versailles, France.ORCID http://orcid.org/0000-0001-5142-0310
Stéphane de BottonDepartment of Hematology, Institut Gustave Roussy, Villejuif, France.
Karine Celli-LebrasALFA office, Saint Louis University Hospital, Paris, France.
Pascal TurlureDepartment of Hematology, Limoges University Hospital, Limoges, France.
Thomas CluzeauDepartment of Hematology, Nice University Hospital, Nice, France.ORCID http://orcid.org/0000-0002-6745-1127
Thorsten BraunDepartment of Hematology, Université Paris Nord, Hôpital Avicenne, AP-HP, Bobigny, France.
Maël HeibligDepartment of Hematology, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France.
Christian RécherUniversity of Toulouse, Toulouse University Hospital, Institut Universitaire du Cancer Toulouse-Oncopole, Department of Hematology, Toulouse, France.ORCID http://orcid.org/0000-0002-3332-4525
Sylvain ChantepieDepartment of Hematology, Caen University Hospital, Caen, France.
Jean-Baptiste MicolDepartment of Hematology, Institut Gustave Roussy, Villejuif, France.ORCID http://orcid.org/0000-0003-0934-294X
Cécile PautasDepartment of Hematology, Henri Mondor Hospital, AP-HP, Créteil, France.
Hervé DombretDepartment of Hematology, Saint Louis University Hospital, AP-HP, Paris, France.
Claude PreudhommeLaboratory of Hematology, CHU Lille, Lille, France.
Raphael ItzyksonDepartment of Hematology, Saint Louis University Hospital, AP-HP, Paris, France.ORCID http://orcid.org/0000-0003-2139-6262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42336836
PMCPMC13547288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.